ENDRA Life Sciences' TAEUS De Novo Submission Advances to Ne

ENDRA Life Sciences Inc. , a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound , announces that the Company's De Novo request for the TAEUS liver system has advanced to...

Related Keywords

Francois Michelon , Endra Life Sciences Inc , Drug Administration , Life Sciences , Securities Exchange , Exchange Commission , Company De Novo , Life Sciences Inc , Sciences Inc , Thermo Acoustic Enhanced Ultrasound , Non Alcoholic Fatty Liver Disease , Chief Executive Officer Francois , Submission Template And Resource , Steatotic Liver Disease , Securities Act , Securities Exchange Act , Risk Factors , Financial Condition , Annual Report , Quarterly Reports , Markets ,